The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy

SH Aghamiri, K Komlakh, M Ghaffari - Inflammopharmacology, 2022 - Springer
Diabetes is correlated with organ failures as a consequence of microvascular diabetic
complications, including neuropathy, nephropathy, and retinopathy. These difficulties come …

Neuropathic pain in multiple sclerosis and its animal models: focus on mechanisms, knowledge gaps and future directions

E Mirabelli, S Elkabes - Frontiers in Neurology, 2021 - frontiersin.org
Multiple sclerosis (MS) is a multifaceted, complex and chronic neurological disease that
leads to motor, sensory and cognitive deficits. MS symptoms are unpredictable and …

Ginsenoside Rh2 inhibits NLRP3 inflammasome activation and improves exosomes to alleviate hypoxia-induced myocardial injury

Z Qi, Z Yan, Y Wang, N Ji, X Yang, A Zhang… - Frontiers in …, 2022 - frontiersin.org
The inflammatory microenvironment after acute myocardial infarction (MI) is a key limiting
factor in the clinical application of stem cell transplantation and paracrine exosome therapy …

Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: targeting NLRP3 inflammasome/TXNIP pathway and autophagy modulation

RM El-Sayed, MN Fawzy, HF Zaki… - International …, 2023 - Elsevier
Recurrent seizures characterize epilepsy, a complicated and multifaceted neurological
disease. Several neurological alterations, such as cell death and the growth of gorse fibers …

[HTML][HTML] Memantine mitigates ROS/TXNIP/NLRP3 signaling and protects against mouse diabetic retinopathy: Histopathologic, ultrastructural and bioinformatic studies

MH ElSayed, KS Elbayoumi, MA Eladl… - Biomedicine & …, 2023 - Elsevier
Diabetic retinopathy (DRET) triggers vision loss in adults, however, little therapeutic options
are existing. Memantine is an anti-Alzheimer drug that antagonizes the activity of glutamate …

Neuroprotective mechanism of Ajugarin-I against Vincristine-Induced neuropathic pain via regulation of Nrf2/NF-κB and Bcl2 signalling

A Khan, B Shal, AU Khan, KU Shah, SS Zahra… - International …, 2023 - Elsevier
Vincristine (VCR) is a well-known chemotherapeutic agent that frequently triggers
neuropathic pain. Ajugarin-I (Aju-I) isolated from Ajuga bracteosa exerts antioxidant, anti …

Glial cell reactivity and oxidative stress prevention in Alzheimer's disease mice model by an optimized NMDA receptor antagonist

J Companys-Alemany, AL Turcu, S Vázquez… - Scientific Reports, 2022 - nature.com
In Alzheimer's disease pathology, several neuronal processes are dysregulated by
excitotoxicity including neuroinflammation and oxidative stress (OS). New therapeutic …

Toll-like receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy

SH Aghamiri, K Komlakh, M Ghaffari - International Immunopharmacology, 2022 - Elsevier
One of the most common diabetic microvascular complications is diabetic neuropathy (DN).
Immune cell infiltration in the peripheral nerve system (PNS), myelin loss, Schwann cell …

The cellular senescence factor extracellular HMGB1 directly inhibits oligodendrocyte progenitor cell differentiation and impairs CNS remyelination

ME Rouillard, J Hu, PA Sutter, HW Kim… - Frontiers in Cellular …, 2022 - frontiersin.org
HMGB1 is a highly conserved, ubiquitous protein in eukaryotic cells. HMGB1 is normally
localized to the nucleus, where it acts as a chromatin associated non-histone binding …

High mobility group box protein (HMGB1): A potential therapeutic target for diabetic encephalopathy

UK Dash, D Mazumdar, S Singh - Molecular Neurobiology, 2024 - Springer
HMGB (high mobility group B) is one of the ubiquitous non-histone nuclear protein
superfamilies that make up the HMG (high mobility group) protein group. HMGB1 is involved …